154 related articles for article (PubMed ID: 37933774)
21. The Benzene Hematotoxic and Reactive Metabolite 1,4-Benzoquinone Impairs the Activity of the Histone Methyltransferase SET Domain Containing 2 (SETD2) and Causes Aberrant Histone H3 Lysine 36 Trimethylation (H3K36me3).
Berthelet J; Michail C; Bui LC; Le Coadou L; Sirri V; Wang L; Dulphy N; Dupret JM; Chomienne C; Guidez F; Rodrigues-Lima F
Mol Pharmacol; 2021 Sep; 100(3):283-294. PubMed ID: 34266924
[TBL] [Abstract][Full Text] [Related]
22. TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling.
Phanish MK; Wahab NA; Hendry BM; Dockrell ME
Nephron Exp Nephrol; 2005; 100(4):e156-65. PubMed ID: 15855807
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats.
Qi FH; Cai PP; Liu X; Si GM
Int J Mol Med; 2018 May; 41(5):3015-3023. PubMed ID: 29436600
[TBL] [Abstract][Full Text] [Related]
24. SETD2 loss in renal epithelial cells drives epithelial-to-mesenchymal transition in a TGF-β-independent manner.
Wang T; Wagner RT; Hlady RA; Pan X; Zhao X; Kim S; Wang L; Lee JH; Luo H; Castle EP; Lake DF; Ho TH; Robertson KD
Mol Oncol; 2024 Jan; 18(1):44-61. PubMed ID: 37418588
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-411-3p inhibits bleomycin-induced skin fibrosis by regulating transforming growth factor-β/Smad ubiquitin regulatory factor-2 signalling.
Zhang Z; Gao X; He Y; Kang Y; Jin F; Li Y; Li T; Wei Z; Li S; Cai W; Mao N; Wang S; Liu H; Yang F; Xu H; Yang J
J Cell Mol Med; 2021 Dec; 25(24):11290-11299. PubMed ID: 34783198
[TBL] [Abstract][Full Text] [Related]
26. TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.
Xu F; Liu C; Zhou D; Zhang L
J Histochem Cytochem; 2016 Mar; 64(3):157-67. PubMed ID: 26747705
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-β/Smad signalling in diabetic nephropathy.
Lan HY
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):731-8. PubMed ID: 22211842
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation.
Carvajal G; Rodríguez-Vita J; Rodrigues-Díez R; Sánchez-López E; Rupérez M; Cartier C; Esteban V; Ortiz A; Egido J; Mezzano SA; Ruiz-Ortega M
Kidney Int; 2008 Sep; 74(5):585-95. PubMed ID: 18509316
[TBL] [Abstract][Full Text] [Related]
29. Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.
Cai P; Liu X; Xu Y; Qi F; Si G
Biosci Trends; 2017; 11(6):640-650. PubMed ID: 29311449
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma.
Ananth S; Knebelmann B; Grüning W; Dhanabal M; Walz G; Stillman IE; Sukhatme VP
Cancer Res; 1999 May; 59(9):2210-6. PubMed ID: 10232610
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-183 exerts a protective role in lupus nephritis through blunting the activation of TGF-β/Smad/TLR3 pathway via reducing Tgfbr1.
Qi H; Cao Q; Liu Q
Exp Cell Res; 2020 Sep; 394(2):112138. PubMed ID: 32535034
[TBL] [Abstract][Full Text] [Related]
32. Praziquantel ameliorates CCl
Liu J; Kong D; Qiu J; Xie Y; Lu Z; Zhou C; Liu X; Zhang R; Wang Y
Br J Pharmacol; 2019 Dec; 176(24):4666-4680. PubMed ID: 31412137
[TBL] [Abstract][Full Text] [Related]
33. Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril.
Huang YR; Wei QX; Wan YG; Sun W; Mao ZM; Chen HL; Meng XJ; Shi XM; Tu Y; Zhu Q
J Ethnopharmacol; 2014 Sep; 155(3):1541-52. PubMed ID: 25087615
[TBL] [Abstract][Full Text] [Related]
34. TGF-β/Smad and Renal Fibrosis.
Ma TT; Meng XM
Adv Exp Med Biol; 2019; 1165():347-364. PubMed ID: 31399973
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-302b mitigates renal fibrosis via inhibiting TGF-β/Smad pathway activation.
Sun M; Zhou W; Yao F; Song J; Xu Y; Deng Z; Diao H; Li S
Braz J Med Biol Res; 2021; 54(3):e9206. PubMed ID: 33503202
[TBL] [Abstract][Full Text] [Related]
36. miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN.
Ai K; Zhu X; Kang Y; Li H; Zhang L
Exp Mol Pathol; 2020 Feb; 112():104358. PubMed ID: 31836508
[TBL] [Abstract][Full Text] [Related]
37. Nur77 ameliorates age-related renal tubulointerstitial fibrosis by suppressing the TGF-β/Smads signaling pathway.
Ma G; Chen F; Liu Y; Zheng L; Jiang X; Tian H; Wang X; Song X; Yu Y; Wang D
FASEB J; 2022 Feb; 36(2):e22124. PubMed ID: 34972249
[TBL] [Abstract][Full Text] [Related]
38. H3K36 trimethylation mediated by SETD2 regulates the fate of bone marrow mesenchymal stem cells.
Wang L; Niu N; Li L; Shao R; Ouyang H; Zou W
PLoS Biol; 2018 Nov; 16(11):e2006522. PubMed ID: 30422989
[TBL] [Abstract][Full Text] [Related]
39. PI3Kβ inhibitor TGX221 selectively inhibits renal cell carcinoma cells with both VHL and SETD2 mutations and links multiple pathways.
Feng C; Sun Y; Ding G; Wu Z; Jiang H; Wang L; Ding Q; Wen H
Sci Rep; 2015 Apr; 5():9465. PubMed ID: 25853938
[TBL] [Abstract][Full Text] [Related]
40. Cross talk between lysine methyltransferase Smyd2 and TGF-β-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease.
Li LX; Zhang L; Agborbesong E; Zhang X; Zhou JX; Li X
Am J Physiol Renal Physiol; 2022 Aug; 323(2):F227-F242. PubMed ID: 35759739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
